These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

435 related articles for article (PubMed ID: 25535823)

  • 41. A review of the first anti-evaporative prescription treatment for dry eye disease: perfluorohexyloctane ophthalmic solution.
    Sheppard JD; Evans DG; Protzko EE
    Am J Manag Care; 2023 Nov; 29(14 Suppl):S251-S259. PubMed ID: 37930231
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A Rabbit Model of Aqueous-Deficient Dry Eye Disease Induced by Concanavalin A Injection into the Lacrimal Glands: Application to Drug Efficacy Studies.
    Honkanen RA; Huang L; Rigas B
    J Vis Exp; 2020 Jan; (155):. PubMed ID: 32065120
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Reconsidering the central role of mucins in dry eye and ocular surface diseases.
    Baudouin C; Rolando M; Benitez Del Castillo JM; Messmer EM; Figueiredo FC; Irkec M; Van Setten G; Labetoulle M
    Prog Retin Eye Res; 2019 Jul; 71():68-87. PubMed ID: 30471351
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Interleukin-17 Receptor E and C-C Motif Chemokine Receptor 10 Identify Heterogeneous T Helper 17 Subsets in a Mouse Dry Eye Disease Model.
    Wang J; Gong J; Yang Q; Wang L; Jian Y; Wang P
    Am J Pathol; 2022 Feb; 192(2):332-343. PubMed ID: 35144761
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Transient tear hyperosmolarity disrupts the neuroimmune homeostasis of the ocular surface and facilitates dry eye onset.
    Guzmán M; Miglio M; Keitelman I; Shiromizu CM; Sabbione F; Fuentes F; Trevani AS; Giordano MN; Galletti JG
    Immunology; 2020 Oct; 161(2):148-161. PubMed ID: 32702135
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The Role of Nano-ophthalmology in Treating Dry Eye Disease.
    Natesan S; Boddu SHS; Krishnaswami V; Shahwan M
    Pharm Nanotechnol; 2020; 8(4):258-289. PubMed ID: 32600244
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A New Rabbit Model of Chronic Dry Eye Disease Induced by Complete Surgical Dacryoadenectomy.
    Honkanen R; Huang W; Huang L; Kaplowitz K; Weissbart S; Rigas B
    Curr Eye Res; 2019 Aug; 44(8):863-872. PubMed ID: 30983427
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The pathology of dry eye: the interaction between the ocular surface and lacrimal glands.
    Stern ME; Beuerman RW; Fox RI; Gao J; Mircheff AK; Pflugfelder SC
    Cornea; 1998 Nov; 17(6):584-9. PubMed ID: 9820935
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Perfluorohexyloctane Ophthalmic Solution: A Review in Dry Eye Disease.
    Zhuang-Yan A; Syed YY
    Drugs; 2024 Apr; 84(4):441-448. PubMed ID: 38554243
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Once-Daily Topical Phosphosulindac Is Efficacious in the Treatment of Dry Eye Disease: Studies in Rabbit Models of Its Main Clinical Subtypes.
    Huang W; Huang L; Li W; Saglam MS; Tourmouzis K; Goldstein SM; Master A; Honkanen R; Rigas B
    J Ocul Pharmacol Ther; 2022; 38(1):102-113. PubMed ID: 34964663
    [No Abstract]   [Full Text] [Related]  

  • 51. Review on the possible pathophysiological mechanisms underlying visual display terminal-associated dry eye disease.
    Fjaervoll K; Fjaervoll H; Magno M; Nøland ST; Dartt DA; Vehof J; Utheim TP
    Acta Ophthalmol; 2022 Dec; 100(8):861-877. PubMed ID: 35441459
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of Dry Eye Disease on the Kinetics of Lacrimal Gland Dendritic Cells as Visualized by Intravital Multi-Photon Microscopy.
    Ortiz G; Chao C; Jamali A; Seyed-Razavi Y; Kenyon B; Harris DL; Zoukhri D; Hamrah P
    Front Immunol; 2020; 11():1713. PubMed ID: 32903439
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Conjunctiva Resident γδ T Cells Expressed High Level of IL-17A and Promoted the Severity of Dry Eye.
    Li L; Li Y; Zhu X; Wu B; Tang Z; Wen H; Yuan J; Zheng Q; Chen W
    Invest Ophthalmol Vis Sci; 2022 Nov; 63(12):13. PubMed ID: 36350619
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Association Between Depression and Severity of Dry Eye Symptoms, Signs, and Inflammatory Markers in the DREAM Study.
    Zhou Y; Murrough J; Yu Y; Roy N; Sayegh R; Asbell P; Maguire MG; Ying GS;
    JAMA Ophthalmol; 2022 Apr; 140(4):392-399. PubMed ID: 35266971
    [TBL] [Abstract][Full Text] [Related]  

  • 55. ICAM-1 expression predisposes ocular tissues to immune-based inflammation in dry eye patients and Sjögrens syndrome-like MRL/lpr mice.
    Gao J; Morgan G; Tieu D; Schwalb TA; Luo JY; Wheeler LA; Stern ME
    Exp Eye Res; 2004 Apr; 78(4):823-35. PubMed ID: 15037117
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The core mechanism of dry eye disease is inflammation.
    Wei Y; Asbell PA
    Eye Contact Lens; 2014 Jul; 40(4):248-56. PubMed ID: 25390549
    [TBL] [Abstract][Full Text] [Related]  

  • 57. CCR7 is critical for the induction and maintenance of Th17 immunity in dry eye disease.
    Kodati S; Chauhan SK; Chen Y; Dohlman TH; Karimian P; Saban D; Dana R
    Invest Ophthalmol Vis Sci; 2014 Aug; 55(9):5871-7. PubMed ID: 25139737
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Inflammatory basis for dry eye disease flares.
    Perez VL; Stern ME; Pflugfelder SC
    Exp Eye Res; 2020 Dec; 201():108294. PubMed ID: 33039458
    [TBL] [Abstract][Full Text] [Related]  

  • 59. sPLA
    Wei Y; Asbell PA
    Exp Eye Res; 2020 Dec; 201():108209. PubMed ID: 33011237
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Dry Eye Disease: Early Recognition with Guidance on Management and Treatment for Primary Care Family Physicians.
    Verjee MA; Brissette AR; Starr CE
    Ophthalmol Ther; 2020 Dec; 9(4):877-888. PubMed ID: 33090327
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.